Federal health experts said Wednesday there is little evidence that testosterone-boosting drugs are effective for treating common signs of aging in men and that their use should be narrowed to exclude millions of Americans ...
Sep 17, 2014
0
0
(HealthDay)—Movantik (naloxegol) has been approved by the U.S. Food and Drug Administration to treat opioid-induced constipation, the agency said Tuesday.
Sep 16, 2014
0
0
Venezuela's chronic shortages have begun to encroach on a cultural cornerstone: the boob job.
Sep 15, 2014
0
0
Federal health experts say a diabetes drug from Novo Nordisk should be approved for a new use in treating obesity.
Sep 11, 2014
0
0
U.S. regulators have greenlighted a new weight-loss drug called Contrave, the third in a string of approvals for prescription medications aimed at the nation's 78 million obese adults.
Sep 11, 2014
0
0
(HealthDay)—The NephroCheck test, designed to predict the risk of sudden kidney injury within 12 hours, has been approved by the U.S. Food and Drug Administration.
Sep 5, 2014
0
0
Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments.
Sep 4, 2014
0
0
The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries ...
Sep 3, 2014
0
0
(HealthDay)— As the fall sports season starts and young players face the risk of concussions, the U.S. Food and Drug Administration warns that dietary supplements that claim to prevent, treat or cure concussions are untested, ...
Aug 27, 2014
0
0
(Medical Xpress)—A popular new ingredient in gluten-free products could be causing an allergic reaction, according to a Kansas State University food safety specialist.
Aug 26, 2014
0
0
